alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 830.310 Information required for unique device identification. The contact for device identification designated under § 830.320(a) shall provide FDA with the following information concerning each version or model of a device required to bear a unique device identifier (UDI) on its label: ( a ) *Concerning the labeler:* ( 1 ) The name of the labeler;
( 2 ) A telephone number or email address that will allow FDA to communicate with the contact for device identification designated under § 830.320(a); and
( 3 ) The name of each issuing agency whose system is used by the labeler to assign UDIs used by the labeler.
( b ) *Concerning each version or model of a device with a UDI on its label:* ( 1 ) The device identifier portion of the UDI assigned to the version or model;
( 2 ) When reporting a substitution of a new device identifier that will be used in lieu of a previously reported identifier, the device identifier that was previously assigned to the version or model;
( 3 ) If § 801.45 of this chapter requires the device to bear a UDI as a permanent marking on the device itself, either: ( i ) A statement that the device identifier that appears as a permanent marking on the device is identical to that reported under paragraph (b)(1) of this section, or
( ii ) The device identifier portion of the UDI that appears as a permanent marking on the device;
( 4 ) The proprietary, trade, or brand name of the device as it appears on the label of the device;
( 5 ) Any version or model number or similar reference that appears on the label of the device;
( 6 ) If the device is labeled as sterile, a statement to that effect;
( 7 ) If the device is labeled as containing natural rubber latex that contacts humans, or is labeled as having packaging containing natural rubber latex that contacts humans, as described by §§ 801.437(b)(1), 801.437(b)(3), and 801.437(f) of this chapter, a statement to that effect;
( 8 ) Whether a patient may be safely exposed to magnetic resonance imaging, nuclear magnetic resonance imaging, or magnetic resonance tomography while using the device, or while the device is implanted in patient.
( 9 ) If the device is available in more than one size, the size of the particular version or model, together with the unit of measure, as it appears on the label of the device;
( 10 ) The type of production identifiers that appear on the label of the device;
( 11 ) The FDA premarket submission number of a cleared or approved device, or a statement that FDA has by regulation exempted the device from premarket notification;
( 12 ) The FDA listing number assigned to the device;
( 13 ) The Global Medical Device Nomenclature (GMDN) term or code for the device;
( 14 ) The total number of individual devices contained in the device package.
#### § 524.981 [Reserved]
Editorial Note on Part 872
Editorial Note: Nomenclature changes to part 872 appear at 73 FR 35341, June 23, 2008.

§ 872.3130 Preformed anchor. ( a ) *Identification.* A preformed anchor is a device made of austenitic alloys or alloys containing 75 percent or greater gold or metals of the platinum group intended to be incorporated into a dental appliance, such as a denture, to help stabilize the appliance in the patient's mouth.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 872.9.
[52 FR 30097, Aug. 12, 1987, as amended at 59 FR 63008, Dec. 7, 1994; 66 FR 38797, July 25, 2001]
# C_2014142EN.01003502.xml

| 12.5.2014 | EN | Official Journal of the European Union | C 142/35 |
| --- | --- | --- | --- |

12.5.2014

EN

Official Journal of the European Union

C 142/35

---

Action brought on 27 January 2014 — BR IP Holder v OHIM — Greyleg Investments (HOKEY POKEY)

(Case T-62/14)

2014/C 142/46

Language in which the application was lodged: English

Parties

Parties

Applicant: BR IP Holder LLC (Canton, United States) (represented by: F. Traub, lawyer, and C. Rohsler, Solicitor)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party to the proceedings before the Board of Appeal: Greyleg Investments Ltd (Baltonsborough, United Kingdom)

Other party to the proceedings before the Board of Appeal:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | Annul the decision of the Fourth Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 22 November 2013 given in Case R 1091/2012-4; |
| --- | --- |

—

Annul the decision of the Fourth Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 22 November 2013 given in Case R 1091/2012-4;

| — | Order the defendant to pay the costs of proceedings. |
| --- | --- |

—

Order the defendant to pay the costs of proceedings.

Pleas in law and main arguments

Pleas in law and main arguments

Applicant for a Community trade mark: The other party to the proceedings before the Board of Appeal

Applicant for a Community trade mark:

Community trade mark concerned: The word mark ‘HOKEY POKEY’ for ‘confectionery’ in Class 30 — Community trade mark application No 9 275 678

Community trade mark concerned:

Proprietor of the mark or sign cited in the opposition proceedings: The applicant

Proprietor of the mark or sign cited in the opposition proceedings:

Mark or sign cited in opposition: Earlier, non-registered trade mark ‘HOKEY POKEY’ claimed to be in use in the United Kingdom for ‘confectionery, namely ice cream’

Mark or sign cited in opposition:

Decision of the Opposition Division: Rejected the opposition in its entirety

Decision of the Opposition Division:

Decision of the Board of Appeal: Dismissed the appeal

Decision of the Board of Appeal:

Pleas in law: Infringement of Article 8(4) CTMR.

Pleas in law:

---
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.3535 Intra-aortic balloon and control system. ( a ) *Identification.* An intra-aortic balloon and control system is a prescription device that consists of an inflatable balloon, which is placed in the aorta to improve cardiovascular functioning during certain life-threatening emergencies, and a control system for regulating the inflation and deflation of the balloon. The control system, which monitors and is synchronized with the electrocardiogram, provides a means for setting the inflation and deflation of the balloon with the cardiac cycle.
( b ) *Classification.* ( 1 ) Class II (special controls) when the device is indicated for acute coronary syndrome, cardiac and non-cardiac surgery, or complications of heart failure. The special controls for this device are: ( i ) Appropriate analysis and non-clinical testing must be conducted to validate electromagnetic compatibility and electrical safety of the device;
( ii ) Software verification, validation, and hazard analysis must be performed;
( iii ) The device must be demonstrated to be biocompatible;
( iv ) Sterility and shelf-life testing must demonstrate the sterility of patient-contacting components and the shelf life of these components;
( v ) Non-clinical performance evaluation of the device must demonstrate mechanical integrity, durability, and reliability to support its intended purpose; and
( vi ) Labeling must include a detailed summary of the device- and procedure-related complications pertinent to use of the device.
( 2 ) Class III (premarket approval) when the device is indicated for septic shock and pulsatile flow generation.
( c ) *Date premarket approval application (PMA) or notice of completion of product development protocol (PDP) is required.* A PMA or notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before March 31, 2014, for any intra-aortic balloon and control system indicated for septic shock or pulsatile flow generation that was in commercial distribution before May 28, 1976, or that has, on or before March 31, 2014, been found to be substantially equivalent to any intra-aortic balloon and control system indicated for septic shock or pulsatile flow generation that was in commercial distribution before May 28, 1976. Any other intra-aortic balloon and control system indicated for septic shock or pulsatile flow generation shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution.
[78 FR 79303, Dec. 31, 2013]
OT REPORT 75-59

REFRACTIVITY GRADIENTS IN
THE NORTHERN HEMISPHERE

C. A. SAMSON

Prepared for

The Deputy Chief of Staff

for Plans and Operations

U.S. Army Communications Command
Ft. Huachuca, Az. 85613

nT OF
e Soy,

wi
¥
Be

Stares of ©

yan * Dep
Ce TM
.

Pea. ae

U.S. DEPARTMENT OF COMMERCE
Frederick B. Dent, Secretary

Betsy Ancker-Johnson, Ph. D.

Assistant Secretary for Science and Technology
yOUTIOn,

& Se, OFFICE OF TELECOMMUNICATIONS
<i Z John M. Richardson, Acting Director
9 nm

=
1We
a
7776-1910 APRIL 1975

For sale by the Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402


UNITED STATES DEPARTMENT OF COMMERCE
OFFICE OF TELECOMMUNICATIONS

STATEMENT OF MISSION

The mission of the Office of Telecommunications in the Department
of Commerce is to assist the Department in fostering, serving, and
promoting the nation’s economic development and technological
advancement by improving man’s comprehension of telecommuni-
cation science and by assuring effective use and growth of the
nation’s telecommunication resources.

In carrying out this mission, the Office

Conducts research needed in the evaluation and development
of policy as required by the Department of Commerce

Assists other government agencies in the use of telecommuni-
cations

Conducts research, engineering, and analysis in the general
field of telecommunication science to meet government needs

Acquires, analyzes, synthesizes, and disseminates information
for the efficient use of the nation’s telecommunication re-
sources.

Performs analysis, engineering, and related administrative
functions responsive to the needs of the Director of the Office
of Telecommunications Policy, Executive Office of the Presi-
dent, in the performance of his responsibilities for the manage-
ment of the radio spectrum

Conducts research needed in the evaluation and development
of telecommunication policy as required by the Office of Tele-
communications Policy, pursuant to Executive Order 11556

ii


TABLE OF CONTENTS

Page
ABSTRACT 1
1. INTRODUCTION 1
2. SOURCE OF DATA 2
3. DATA PRESENTATION 4
4. DISCUSSION 8
5. CONCLUSIONS 13
6. ACKNOWLEDGMENT 13
7. REFERENCES 15
APPENDIX A: Calculation of Refractivity 17
APPENDIX B: The Normal Refractivity Gradient 20
APPENDIX C: Cumulative Distributions of the
Observed Radio Refractivity Gradient
in the Ground-based 100-meter Layer 23
STATION INDEX 24
APPENDIX D: Errata and Supplementary Remarks for "A
World Atlas of Atmospheric Radio
Refractivity" 118
FIGURES
Figure l. Location of stations for which refractivity
gradient data are given in Appendix C 3
Figure 2. Domestic radiosonde network of the U.S.
National Weather Service 5
Figure 3. Relationship between sunrise/sunset times and the
standard RAOB release time at Fort Smith,N.W.T. 10
Figure 4. Minimum effective value of "k" as a function of
path length 12
Figure A-l. Refractive index nomogram 19
Figure B-1. Annual median 100-m refractivity gradient 21
Figure B-2. February and August median values of 100-m
refractivity gradient 22

iii
EXHIBIT 32.a



CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of American Affordable Housing II Limited Partnership (the "Partnership") on Form 10-Q for the period ended December 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, John P. Manning, Principal Executive Officer of the general partner of the general partner of the Partnership's general partner, C&M Management Inc., certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge, after due inquiry:



|(1) | The Report fully complies with the requirements of section 13(a)-15 or 15(d)-15 of the Securities and Exchange Act of 1934; and                        
|--- | -------------------------------------------------------------------------------------------------------------------------------------------------------
|    |                                                                                                                                                        
|(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Partnership.



|                  |     |                            
|----------------- | --- | ---------------------------
|Date:             |     |                            
|February 23, 2007 | By: | /s/ John P. Manning        
|                  |     |                            
|                  |     | John P. Manning            
|                  |     | Principal Executive Officer

A signed original of this written statement required by Section 906, or other

document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Fund and will be retained by the Fund and furnished to the Securities and Exchange Commission or its staff upon request.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Federal Energy Regulatory Commission

          - [Docket No. AD06-6-000]

      ( print page 11166)    
The Federal Energy Regulatory Commission (FERC) and the Nuclear Regulatory Commission (NRC) will hold a joint meeting on Tuesday, March 16, 2010 at the headquarters of the NRC, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. The meeting is expected to begin at 1:30 p.m. and conclude at 3:30 p.m. Eastern Standard Time.

The NRC and FERC signed a Memorandum of Agreement (MOA) in September 2010 to facilitate interactions between the two agencies on matters of mutual interest pertaining to the nation's bulk power system reliability. The March 16 meeting will continue the ongoing discussion to address grid reliability and the roles of the respective agencies in addressing this issue.

                    A free Webcast of this event will be made available through the NRC Web site, at                     *http://www.nrc.gov.*                     In addition, the event will be transcribed and the transcription will be made available through the NRC Web site approximately three business days after the meeting.                

                    All interested persons are invited. Pre-registration is not required and there is no fee to attend this joint meeting. Questions about the meeting should be directed to Sarah McKinley at                     *Sarah.McKinley@ferc.gov*                     or by phone at 202-502-8004.                

Kimberly D. Bose,

Secretary.

[FR Doc. 2010-5005 Filed 3-9-10; 8:45 am]

BILLING CODE 6717-01-P
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.1570 Powered direct-contact temperature measurement device. ( a ) *Identification.* A powered direct-contact temperature measurement device is a device which contains a power source and is used to measure differences in temperature between two points on the body.
( b ) *Classification.* Class II (performance standards).
Final Listing of Questionnaire Files for Steam Electric Rulemaking Record

Plant ID 08676

Removed 

from Public 

(Non-CBI) 

Docket1

Copyright 

Flag2

File Name Description

x 08676\08676_Checklist.xls EPA Technical Review Checklist Workbook

08676\08676_Completeness_Checklist.xls EPA Completeness Review Checklist

08676\08676_HardcopyLog.doc EPA log of hardcopy documents submitted

x 08676\08676_PartA.xls Plant submitted survey file

08676\Certification Statement_Plant ID_08676.pdf Plant certification statement

1

 Final reviewed survey responses are located in the Steam Electric Technical Questionnaire Database . 

2

 Copyright documents are available from the docket.
### I N T H E U N I T E D S T A T E S C O U R T O F A P P E A L S F O R T H E F I F T H C I R C U I T

N o

. 1 0

- 2 0 0 2 6 S u m m a r y C a l e n d a r

D O N A V A N A M O R R I S L O N D O N ,
P l a i n t i f f

- A p p e l l a n t

v
.
F E D E R A L B U R E A U O F I N V E S T I G A T I O N S ( F B I ) ,
D e f e n d a n t

- A p p e l l e e

A p p e a l f

r o m t h e U n i t e d S t a t e s D i s t r i c t C o u r t f o r t h e S o u t h e r n D i s t r i c t o f T e x a s N o

. 4 : 0 9

- C V

- 2 9 7 9

B e f o r e K I N G , J O L L Y , a n d G A R Z A , C i r c u i t J u d g e s

. P E R C U R I A M : *
D o n a v a n A m o r r i s L o n d o n , p r o c e e d i n g p r o s e , h a s s u e d t h e F B I u n d e r 4 2
U

. S

. C

. § 1 9 8 3 , w h i c h d o e s n o t a p p l y t o t h e f e d e r a l g o v e r n m e n t , A f f i l i a t e d
P r o f e s s i o n a l Ho m e H

e a l t h C a r e A g e n c y v

. S h a l a l a , 1 6 4 F

. 3 d 2 8 2 , 2 8 6 ( 5 t h C i r

. 1 9 9 9 )

. T h e d i s t r i c t c o u r t ’ s d i s m i s s a l w a s a p p r o p r i a t e

. A l l o u t s t a n d i n g m o t i o n s i n t h i s c a s e a r e D E N I E D

. T h e j u d g m e n t o f t h e d i s t r i c t c o u r t i s A F F I R M E D

. U n i te d S ta te s C o u rt o f A p p ea l s

F i ft h C i rc u i t 

### F I L E D July 30, 2 010
Lyle W . Cayce Clerk

Pur sua nt to 5 T H C I R . R. 47.5 , the cour t has d ete rm ined t hat this op inion sho uld not * be publ ish ed and is not pr ece dent excep t unde r the lim ite d cir cum st ance s se t for th in 5 T H C I R

. R. 47.5 .4. Case: 10-20026 Document: 00511190061 Page: 1 Date Filed: 07/30/2010
# C_2014303EN.01004701.xml

| 8.9.2014 | EN | Official Journal of the European Union | C 303/47 |
| --- | --- | --- | --- |

8.9.2014

EN

Official Journal of the European Union

C 303/47

---

Action brought on 3 July 2014 — Staywell Hospitality Group v. OHIM — Sheraton International IP (PARK REGIS)

(Case T-510/14)

2014/C 303/55

Language in which the application was lodged: English

Parties

Parties

Applicant: Staywell Hospitality Group Pty Ltd (Sydney, Australia) (represented by: D. Farnsworth, Solicitor)

Applicant:

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant:

Other party to the proceedings before the Board of Appeal: Sheraton International IP LLC (Stamford, United States of America)

Other party to the proceedings before the Board of Appeal:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the decision of the Fifth Board of Appeal of 30 April 2014 in Cases R 240/2013-5 and R 303/2013-5 insofar as it concerns Case R 240/2013-5; and |
| --- | --- |

—

annul the decision of the Fifth Board of Appeal of 30 April 2014 in Cases R 240/2013-5 and R 303/2013-5 insofar as it concerns Case R 240/2013-5; and

| — | condemn the Defendant to bear its own and pay the Applicant’s costs. |
| --- | --- |

—

condemn the Defendant to bear its own and pay the Applicant’s costs.

Pleas in law and main arguments

Pleas in law and main arguments

Applicant for a Community trade mark: The applicant

Applicant for a Community trade mark:

Community trade mark concerned: The figurative mark containing the word elements ‘PARK REGIS’ for services in Classes 35, 36 and 43 — Community trade mark application No 9 4 88  933

Community trade mark concerned:

Proprietor of the mark or sign cited in the opposition proceedings: Sheraton International IP LLC

Proprietor of the mark or sign cited in the opposition proceedings:

Mark or sign cited in opposition: The figurative and word marks ‘ST. REGIS’ for services in Classes 36, 42 and 43, the international trade mark registration designating the European Union of the word mark ‘ST. REGIS’ for services in Class 36 as well as the well-known figurative and word marks ‘ST. REGIS’ in the European Union

Mark or sign cited in opposition:

Decision of the Opposition Division: The opposition was partially upheld

Decision of the Opposition Division:

Decision of the Board of Appeal: The appeals were dismissed

Decision of the Board of Appeal:

Pleas in law: Infringement of Article 8 (1) (b) of Regulation No 207/2009

Pleas in law:

---